Skip to main content
Clinical Trials/NCT05736237
NCT05736237
Completed
Not Applicable

Identification and Verification of Candidate Genes Responsible for Optic Disc Drusen

Copenhagen University Hospital at Herlev1 site in 1 country20 target enrollmentMay 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Optic Disk Drusen
Sponsor
Copenhagen University Hospital at Herlev
Enrollment
20
Locations
1
Primary Endpoint
Candidate gene
Status
Completed
Last Updated
last year

Overview

Brief Summary

The goal of this observational study is to learn about the genetic background for the development of optic disc drusen. The main question is:

• Can one or more candidate genes be found?

Participants will have a blood sample taken and answer a questionnaire.

Detailed Description

The study is an international collaboration between University of Utah, University of Sydney, University of Valladolid, and University of Copenhagen. Patients with Optic disc drusen from 15 known optic disc drusen-families from different countries (USA, Australia, Spain and Denmark) are participating in this study. Blood samples are drawn from each patient and their affected and unaffected family members, and DNA will be extracted. The investigators will do an Optical coherence tomography-scan (according to ODDS Consortium guidelines), and the participant will be asked to fill out the Visual Function Questionnaire (VFQ-25) including four additional questions about optic disc drusen. The etiology of optic disc drusen will be analyzed with a Whole Exome Sequencing (WES), with the use of Next Generation Sequencing (NGS). Prior to WES, all participants will receive genetic counseling by a consultant to ensure awareness of possible secondary genetic findings.

Registry
clinicaltrials.gov
Start Date
May 1, 2023
End Date
May 31, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Copenhagen University Hospital at Herlev
Responsible Party
Principal Investigator
Principal Investigator

Alvilda Steensberg

Principal Investigator

Rigshospitalet, Denmark

Eligibility Criteria

Inclusion Criteria

  • Adult patients over the age of 18, who are capable of giving consent
  • Diagnosis of optic disc drusen and a minimum of 3 optic disc drusen-affected family members

Exclusion Criteria

  • Less than 3 affected family members
  • Under the age of 18 or mentally disabled

Outcomes

Primary Outcomes

Candidate gene

Time Frame: 2023-2024

Genetics variants shared by the families will be compared with findings in the remaining families and identical genes will undergo further analysis.

Study Sites (1)

Loading locations...

Similar Trials